Schwab Charles Investment Management Inc. grew its holdings in Laboratory Corporation of America Holdings (NYSE:LH) by 3.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 345,817 shares of the medical research company’s stock after purchasing an additional 10,311 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.34% of Laboratory Corporation of America worth $52,208,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of LH. Strs Ohio raised its position in shares of Laboratory Corporation of America by 3.4% in the second quarter. Strs Ohio now owns 13,446 shares of the medical research company’s stock valued at $2,072,000 after purchasing an additional 448 shares during the period. NGAM Advisors L.P. increased its holdings in Laboratory Corporation of America by 15.8% during the 2nd quarter. NGAM Advisors L.P. now owns 21,045 shares of the medical research company’s stock worth $3,244,000 after acquiring an additional 2,864 shares during the period. Janney Montgomery Scott LLC increased its holdings in Laboratory Corporation of America by 30.0% during the 2nd quarter. Janney Montgomery Scott LLC now owns 6,709 shares of the medical research company’s stock worth $1,034,000 after acquiring an additional 1,548 shares during the period. Rothschild Asset Management Inc. increased its holdings in Laboratory Corporation of America by 6.6% during the 2nd quarter. Rothschild Asset Management Inc. now owns 3,203 shares of the medical research company’s stock worth $494,000 after acquiring an additional 197 shares during the period. Finally, Candriam Luxembourg S.C.A. increased its holdings in Laboratory Corporation of America by 1.7% during the 2nd quarter. Candriam Luxembourg S.C.A. now owns 25,648 shares of the medical research company’s stock worth $3,954,000 after acquiring an additional 424 shares during the period. 91.45% of the stock is currently owned by institutional investors.

Laboratory Corporation of America Holdings (NYSE LH) traded down $2.69 during mid-day trading on Wednesday, reaching $155.22. 573,400 shares of the company’s stock were exchanged, compared to its average volume of 723,059. The company has a current ratio of 1.89, a quick ratio of 1.75 and a debt-to-equity ratio of 1.18. Laboratory Corporation of America Holdings has a fifty-two week low of $123.41 and a fifty-two week high of $164.22. The stock has a market cap of $16,075.24, a PE ratio of 16.98, a PEG ratio of 1.68 and a beta of 0.87.

Laboratory Corporation of America (NYSE:LH) last released its quarterly earnings results on Wednesday, October 25th. The medical research company reported $2.46 EPS for the quarter, topping the Zacks’ consensus estimate of $2.38 by $0.08. Laboratory Corporation of America had a net margin of 7.40% and a return on equity of 16.75%. The business had revenue of $2.60 billion during the quarter, compared to analysts’ expectations of $2.55 billion. During the same quarter in the previous year, the company earned $2.25 EPS. The business’s quarterly revenue was up 9.5% compared to the same quarter last year. sell-side analysts forecast that Laboratory Corporation of America Holdings will post 9.52 earnings per share for the current fiscal year.

In other Laboratory Corporation of America news, Director Dwight Gary Gilliland sold 971 shares of the business’s stock in a transaction that occurred on Monday, October 30th. The shares were sold at an average price of $153.52, for a total value of $149,067.92. Following the completion of the transaction, the director now owns 3,501 shares of the company’s stock, valued at approximately $537,473.52. The transaction was disclosed in a filing with the SEC, which is available through this link. 0.90% of the stock is owned by insiders.

LH has been the topic of a number of analyst reports. SunTrust Banks reaffirmed a “buy” rating and set a $190.00 target price on shares of Laboratory Corporation of America in a report on Thursday, October 12th. Canaccord Genuity reaffirmed a “buy” rating and set a $180.00 target price (up previously from $175.00) on shares of Laboratory Corporation of America in a report on Monday, September 11th. ValuEngine raised shares of Laboratory Corporation of America from a “hold” rating to a “buy” rating in a report on Wednesday, September 6th. Zacks Investment Research raised shares of Laboratory Corporation of America from a “hold” rating to a “buy” rating and set a $173.00 target price on the stock in a report on Thursday, September 21st. Finally, Craig Hallum reaffirmed a “buy” rating and set a $180.00 target price (up previously from $175.00) on shares of Laboratory Corporation of America in a report on Thursday, October 26th. Six analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $170.92.

TRADEMARK VIOLATION WARNING: “Schwab Charles Investment Management Inc. Boosts Stake in Laboratory Corporation of America Holdings (LH)” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/12/06/schwab-charles-investment-management-inc-boosts-stake-in-laboratory-corporation-of-america-holdings-lh.html.

Laboratory Corporation of America Company Profile

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corporation of America Holdings (NYSE:LH).

Institutional Ownership by Quarter for Laboratory Corporation of America (NYSE:LH)

Receive News & Stock Ratings for Laboratory Corporation of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corporation of America Holdings and related stocks with our FREE daily email newsletter.